Axsome Therapeutics (AXSM)
(Delayed Data from NSDQ)
$103.02 USD
+1.64 (1.62%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $103.04 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Axsome Therapeutics, Inc. has a market cap of $4.99B, which represents its share price of $101.38 multiplied by its outstanding shares number of 49.24M. As a mid-cap company, AXSM's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
AXSM 103.02 +1.64(1.62%)
Will AXSM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AXSM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AXSM
Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth
Axsome Therapeutics (AXSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
AXSM: What are Zacks experts saying now?
Zacks Private Portfolio Services
ALKS Down Despite Positive Top-Line Data From Narcolepsy Study
Here's Why Harmony Biosciences Is an Unconventional Cannabis Investment
Why Is Axsome (AXSM) Down 1.8% Since Last Earnings Report?
Other News for AXSM
A Look at Axsome Therapeutics's Upcoming Earnings Report
Axsome: Some Recent Setbacks, Some Recent Wins -- Still A Buy
Axsome Therapeutics Breaks Below 200-Day Moving Average - Notable for AXSM
Axsome Therapeutics (AXSM) to Highlight CNS Pipeline at R&D Day | AXSM Stock News
Axsome Therapeutics Inc (AXSM) Hosts Frontiers in Brain Health R&D Day | AXSM stock news